Vacinas
Estudo de coorte | Incidência de síndrome torácica aguda em crianças com doença falciforme após implementação da vacina pneumocócica conjugada 13-valente.
5 Ago, 2022 | 16:06h
Comentário no Twitter
#OrigInvestigation: Reduction of acute chest syndrome incidence in children with sickle-cell disease following 13-valent pneumococcal conjugate vaccine (PCV13) implementation in France. https://t.co/MuG6T0g5FU
— JAMA Network Open (@JAMANetworkOpen) August 2, 2022
Respostas às 7 questões mais urgentes sobre a vacina contra varíola dos macacos – “Temos opções seguras e efetivas – porém, com poucos suprimentos.”
18 Jul, 2022 | 13:35h7 of your most pressing monkeypox vaccine questions, answered – Vox
Conteúdos relacionados:
How contagious is monkeypox—and should you get a vaccine? Here’s the latest. – National Geographic
Prevention and Treatment of Monkeypox – Drugs
Monkeypox soars in Europe, with more than 4,000 cases – CIDRAP
No room for complacency – World Health Organization
Multi-country monkeypox outbreak: situation update – World Health Organization
Monkeypox Genital Lesions – New England Journal of Medicine
Monkeypox vaccination begins — can the global outbreaks be contained? – Nature
Incubation period for monkeypox: Estimates from the Netherlands.
‘Discriminatory and stigmatizing’: Scientists push to rename monkeypox viruses – STAT
Rename monkeypox strains to remove geographic stigma, researchers say – Science
2022 Monkeypox and Orthopoxvirus Outbreak Global Map – Centers for Disease Control and Prevention
As monkeypox threat grows, scientists debate best vaccine strategy – Science
Monkeypox is a new global threat. African scientists know what the world is up against – Science
Experts highlight sexual aspect of monkeypox spread – CIDRAP
What to Know About Monkeypox – JAMA
Multi-country monkeypox outbreak in non-endemic countries: Update – World Health Organization
Monkeypox outbreaks: 4 key questions researchers have – Nature
Study reports first use of antivirals in monkeypox patients – Lancet
Surveillance, case investigation and contact tracing for Monkeypox – World Health Organization
Laboratory testing for the monkeypox virus: Interim guidance – World Health Organization
A Novel International Monkeypox Outbreak – Annals of Internal Medicine
EU health agency warns monkeypox could become endemic in Europe if outbreak continues – STAT
Monkeypox cases increase across Europe, North America – CIDRAP
Multi-country monkeypox outbreak in non-endemic countries – World Health Organization
Monkeypox goes global: why scientists are on alert – Nature
Monkeypox: What do we know about the outbreaks in Europe and North America? – The BMJ
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – STAT
Monkeypox: Time to worry or one to ignore? – BBC
UK, Spain, Portugal report more monkeypox cases – CIDRAP
U.S. monkeypox case reported, as Spain, Portugal report infections in growing outbreak – STAT
Monkeypox – United Kingdom of Great Britain and Northern Ireland – World Health Organization
Monkeypox cases confirmed in England – latest updates – UK Health Security Agency
Seven Confirmed Monkeypox Cases in UK Includes Sexually Transmitted Cluster – Health Policy Watch
European outbreak of monkeypox: what you need to know – The Conversation
Rare monkeypox outbreak in U.K., Europe and U.S.: What is it and should we worry – NPR
Monkeypox cases under investigation in Canada as outbreak spreads in Europe, U.S. – CBC News
FDA autoriza o uso emergencial da vacina Novavax contra COVID-19.
18 Jul, 2022 | 13:01hComentários:
FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts – STAT
US regulators OK new COVID-19 shot option from Novavax – Associated Press
Estudo de coorte de abrangência nacional | Segurança dos esquemas de vacinação primária heteróloga e reforços com vacinas ChAdOx1-S e BNT162b2 ou mRNA-1273.
18 Jul, 2022 | 12:54h
European Medicines Agency recomenda reforço de vacina contra COVID em pessoas com mais de 60 anos.
12 Jul, 2022 | 11:54h
Estudo de caso controle e teste negativo | Efetividade da 4ª dose de vacina de mRNA contra Covid-19 causada pela variante Ômicron entre residentes de instituições de longa permanência em Ontário, Canadá.
8 Jul, 2022 | 11:30h
Revisão | O momento de hesitação da vacina.
7 Jul, 2022 | 12:21hThe Vaccine-Hesitant Moment – New England Journal of Medicine
Riscos específicos relacionados a idade e sexo para miocardite e pericardite após vacinação contra Covid-19 com vacinas de RNA mensageiro.
7 Jul, 2022 | 12:20hOpinião | FDA: não faça nenhum movimento para mudar a composição da vacina contra Covid-19.
5 Jul, 2022 | 11:59hFDA: Don’t rush a move to change the Covid-19 vaccine composition – STAT
Estudo de coorte | Efetividade das vacinas Pfizer, Moderna e AstraZeneca contra desfechos graves de Covid-19 em um cenário de vacinação em massa de abrangência nacional.
4 Jul, 2022 | 12:16h
Comentário no Twitter
🎉 Read our latest research article comparing the effectiveness of three #COVID vaccines against severe COVID outcomes. ▶️ https://t.co/uaQNgnDrrV#BMJMedicine #MedTwitter #openaccess pic.twitter.com/4oeG5d0j80
— BMJMedicine (@BMJMedicine) June 16, 2022